|
Ibritumomab Tiuxetan (ib-ri-TU-moe-mab ) (tie-ux-EH-tan) is a protein called a monoclonal antibody. It is used along with another monoclonal antibody (rituximab) and two radioactive pharmaceuticals (In-111 and Y-90). Ibritumomab Tiuxetan is used to treat a type of cancer called non-Hodgkin's lymphoma. Ibritumomab Tiuxetan is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage form: Parenteral Injection (U.S.)
Brand names: - Ibritumomab Tiuxetan - Zevalin |